Author Topic: (Abst.) Predictors of relapse and disability progression in MS patients who stop DMT  (Read 135 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9821
  • MS diagnosed 1980
  • Location: Pacific Northwest

Abstract of "Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy" in Journal of the Neurological Sciences (June 2, 2018):


https://www.sciencedirect.com/science/article/pii/S0022510X1830251X

MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
109 Views
Last post June 22, 2016, 05:19:31 pm
by agate
0 Replies
78 Views
Last post November 02, 2018, 07:33:40 am
by agate
0 Replies
121 Views
Last post June 08, 2019, 09:32:13 am
by agate
0 Replies
27 Views
Last post March 26, 2022, 04:04:30 pm
by agate
0 Replies
25 Views
Last post May 27, 2022, 09:38:47 pm
by agate